Literature DB >> 22779967

Total laparoscopic hysterectomy for early stage endometrial cancer in obese and morbidly obese women.

A Farthing1, J Chatterjee, P Joglekar-Pai, E Dorney, S Ghaem-Maghami.   

Abstract

This is a retrospective observational study, where we have evaluated the role of total laparoscopic hysterectomy (TLH) in obese and morbidly obese patients with early stage endometrial cancer. Our study illustrates that low conversion rates are achievable when appropriately trained surgeons undertake this procedure. All the women with high BMI were operated on laparoscopically in preference to laparotomy, unless there was an obvious contraindication such as a very large uterus or disseminated disease. We have also shown low conversation and complication rates for our patients, in particular a low rate of wound infection. This is in contrast to the high rate of wound infection and prolonged hospital stay reported for obese patients in the literature. Our study shows that TLH for endometrial cancer in obese women is feasible, safe and is likely to be cost-effective and adds to the weight of evidence for its use in this condition.

Entities:  

Mesh:

Year:  2012        PMID: 22779967     DOI: 10.3109/01443615.2012.693990

Source DB:  PubMed          Journal:  J Obstet Gynaecol        ISSN: 0144-3615            Impact factor:   1.246


  9 in total

1.  Endometrial cancer in morbidly obese women: do racial disparities affect surgical or survival outcomes?

Authors:  M L Cote; J J Ruterbusch; Q Ahmed; S Bandyopadhyay; B Alosh; E Abdulfatah; S Seward; R Morris; R Ali-Fehmi
Journal:  Gynecol Oncol       Date:  2014-04       Impact factor: 5.482

Review 2.  Clinical management of obese patients with cancer.

Authors:  Wenjing Tao; Jesper Lagergren
Journal:  Nat Rev Clin Oncol       Date:  2013-07-16       Impact factor: 66.675

3.  Laparoscopy versus laparotomy for the management of endometrial carcinoma in morbidly obese patients: a prospective study.

Authors:  Özgür Bige; Ahmet Demir; Bahadır Saatli; Meral Koyuncuoğlu; Uğur Saygılı
Journal:  J Turk Ger Gynecol Assoc       Date:  2015-07-14

4.  A comparison of open surgery, robotic-assisted surgery and conventional laparoscopic surgery in the treatment of morbidly obese endometrial cancer patients.

Authors:  Alberto A Mendivil; Mark A Rettenmaier; Lisa N Abaid; John V Brown; John P Micha; Katrina L Lopez; Bram H Goldstein
Journal:  JSLS       Date:  2015 Jan-Mar       Impact factor: 2.172

Review 5.  Hysterectomy in very obese and morbidly obese patients: a systematic review with cumulative analysis of comparative studies.

Authors:  Mathijs D Blikkendaal; Evelyn M Schepers; Erik W van Zwet; Andries R H Twijnstra; Frank Willem Jansen
Journal:  Arch Gynecol Obstet       Date:  2015-03-13       Impact factor: 2.344

6.  Feasibility and safety of laparoscopic surgery for obese Korean women with endometrial cancer: long-term results at a single institution.

Authors:  Min-Hyun Baek; Shin-Wha Lee; Jeong-Yeol Park; Daeyeon Kim; Jong-Hyeok Kim; Yong-Man Kim; Young-Tak Kim; Joo-Hyun Nam
Journal:  J Korean Med Sci       Date:  2014-11-04       Impact factor: 2.153

7.  Treatment of endometrial cancer in patient with malignant obesity.

Authors:  Miroslav D Popovic; Arnela Ceric Banicevic; Biljana Popovic; Amela Ceric; Andrija Banicevic; Danijela Popadic
Journal:  Med Arch       Date:  2014

Review 8.  Can Teamwork and High-Volume Experience Overcome Challenges of Lymphadenectomy in Morbidly Obese Patients (Body Mass Index of 40 kg/m2 or Greater) with Endometrial Cancer?: A Cohort Study of Robotics and Laparotomy and Review of Literature.

Authors:  Hubert Fornalik; Temeka Zore; Nicole Fornalik; Todd Foster; Adrian Katschke; Gary Wright
Journal:  Int J Gynecol Cancer       Date:  2018-06       Impact factor: 3.437

9.  Safety of total laparoscopic modified radical hysterectomy with or without lymphadenectomy for endometrial cancer.

Authors:  Masakazu Kitagawa; Kayo Katayama; Atsuko Furuno; Yukiko Okada; Asuna Yumori; Hideya Sakakibara; Hiroyuki Shigeta; Hiroshi Yoshida
Journal:  Gynecol Minim Invasive Ther       Date:  2016-05-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.